Clinical study of aumolertinib versus osimertinib in the treatment of EGFR-mutated advanced non-small cell lung cancer.
Saved in:
| Title: | Clinical study of aumolertinib versus osimertinib in the treatment of EGFR-mutated advanced non-small cell lung cancer. |
|---|---|
| Authors: | Yang SX; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China., Zhu JD; Department of Pharmacy, The People's Hospital of Yongshan County, Zhaotong, 657300, China., Ma L; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China., Pan Y; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China., Li QR; Department of Pharmacy, The People's Hospital of Chuxiong Yi Autonomo, Chuxiong, 675000, China., Tu WL; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China. tuwenlian18@aliyun.com., Zhang ZQ; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China. 564267128@qq.com. |
| Source: | Discover oncology [Discov Oncol] 2025 Oct 06; Vol. 16 (1), pp. 1818. Date of Electronic Publication: 2025 Oct 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41051581 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical study of aumolertinib versus osimertinib in the treatment of EGFR-mutated advanced non-small cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yang+SX%22">Yang SX</searchLink>; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.<br /><searchLink fieldCode="AU" term="%22Zhu+JD%22">Zhu JD</searchLink>; Department of Pharmacy, The People's Hospital of Yongshan County, Zhaotong, 657300, China.<br /><searchLink fieldCode="AU" term="%22Ma+L%22">Ma L</searchLink>; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.<br /><searchLink fieldCode="AU" term="%22Pan+Y%22">Pan Y</searchLink>; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China.<br /><searchLink fieldCode="AU" term="%22Li+QR%22">Li QR</searchLink>; Department of Pharmacy, The People's Hospital of Chuxiong Yi Autonomo, Chuxiong, 675000, China.<br /><searchLink fieldCode="AU" term="%22Tu+WL%22">Tu WL</searchLink>; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China. tuwenlian18@aliyun.com.<br /><searchLink fieldCode="AU" term="%22Zhang+ZQ%22">Zhang ZQ</searchLink>; Department of Clinical Pharmacy, The First People's Hospital of Yunnan Province/The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650032, China. 564267128@qq.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101775142%22">Discover oncology</searchLink> [Discov Oncol] 2025 Oct 06; Vol. 16 (1), pp. 1818. <i>Date of Electronic Publication: </i>2025 Oct 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101775142 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2730-6011 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227306011%22">27306011 </searchLink><i>NLM ISO Abbreviation: </i>Discov Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41051581 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12672-025-03642-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1818 Titles: – TitleFull: Clinical study of aumolertinib versus osimertinib in the treatment of EGFR-mutated advanced non-small cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yang SX – PersonEntity: Name: NameFull: Zhu JD – PersonEntity: Name: NameFull: Ma L – PersonEntity: Name: NameFull: Pan Y – PersonEntity: Name: NameFull: Li QR – PersonEntity: Name: NameFull: Tu WL – PersonEntity: Name: NameFull: Zhang ZQ IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 10 Text: 2025 Oct 06 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2730-6011 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Discover oncology Type: main |
| ResultId | 1 |
